Histopathology Services - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510245394

Publication Date:

October 25, 2024

Pages:

108

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Histopathology services are used for the microscopic examination of biological tissues in disease diagnosis. With the help of imaging techniques, biopsy tissues can be obtained from certain inaccessible sites, such as pancreas and peritoneum.
The global market for Histopathology Services was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Histopathology Services was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Histopathology Services was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Histopathology Services was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Histopathology Services include Sonic Healthcare Limited, Laboratory Corporation of America Holdings, Acculabs Diagnostics UK Ltd, TPL Path Labs, UNILABS, Cureline Global Translational CRO, Targos, Cellular Pathology Services and Experimental Pathology Laboratories Inc (EPL), etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Histopathology Services, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Histopathology Services by region & country, by Type, and by Application.
The Histopathology Services market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Histopathology Services.
麻豆原创 Segmentation
By Company
Sonic Healthcare Limited
Laboratory Corporation of America Holdings
Acculabs Diagnostics UK Ltd
TPL Path Labs
UNILABS
Cureline Global Translational CRO
Targos
Cellular Pathology Services
Experimental Pathology Laboratories Inc (EPL)
CHARLES RIVER LABORATORIES, INC.
Segment by Type:
Surgical Specimen
Breast Biopsy
Lung Biopsy
Renal Biopsy
Gastrointestinal Biopsy
Pancreatic Biopsy
Skin Tissue Biopsy
Testicular Biopsy
Others
Segment by Application
Diagnostic Laboratories & Reference Laboratories
Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Histopathology Services manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Histopathology Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Histopathology Services in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Histopathology Services Product Introduction
1.2 Global Histopathology Services 麻豆原创 Size Forecast
1.3 Histopathology Services 麻豆原创 Trends & Drivers
1.3.1 Histopathology Services Industry Trends
1.3.2 Histopathology Services 麻豆原创 Drivers & Opportunity
1.3.3 Histopathology Services 麻豆原创 Challenges
1.3.4 Histopathology Services 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Histopathology Services Players Revenue Ranking (2023)
2.2 Global Histopathology Services Revenue by Company (2019-2024)
2.3 Key Companies Histopathology Services Manufacturing Base Distribution and Headquarters
2.4 Key Companies Histopathology Services Product Offered
2.5 Key Companies Time to Begin Mass Production of Histopathology Services
2.6 Histopathology Services 麻豆原创 Competitive Analysis
2.6.1 Histopathology Services 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Histopathology Services Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Histopathology Services as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Surgical Specimen
3.1.2 Breast Biopsy
3.1.3 Lung Biopsy
3.1.4 Renal Biopsy
3.1.5 Gastrointestinal Biopsy
3.1.6 Pancreatic Biopsy
3.1.7 Skin Tissue Biopsy
3.1.8 Testicular Biopsy
3.1.9 Others
3.2 Global Histopathology Services Sales Value by Type
3.2.1 Global Histopathology Services Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Histopathology Services Sales Value, by Type (2019-2030)
3.2.3 Global Histopathology Services Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Diagnostic Laboratories & Reference Laboratories
4.1.2 Research Institutes
4.1.3 Others
4.2 Global Histopathology Services Sales Value by Application
4.2.1 Global Histopathology Services Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Histopathology Services Sales Value, by Application (2019-2030)
4.2.3 Global Histopathology Services Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Histopathology Services Sales Value by Region
5.1.1 Global Histopathology Services Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Histopathology Services Sales Value by Region (2019-2024)
5.1.3 Global Histopathology Services Sales Value by Region (2025-2030)
5.1.4 Global Histopathology Services Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Histopathology Services Sales Value, 2019-2030
5.2.2 North America Histopathology Services Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Histopathology Services Sales Value, 2019-2030
5.3.2 Europe Histopathology Services Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Histopathology Services Sales Value, 2019-2030
5.4.2 Asia Pacific Histopathology Services Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Histopathology Services Sales Value, 2019-2030
5.5.2 South America Histopathology Services Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Histopathology Services Sales Value, 2019-2030
5.6.2 Middle East & Africa Histopathology Services Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Histopathology Services Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Histopathology Services Sales Value
6.3 United States
6.3.1 United States Histopathology Services Sales Value, 2019-2030
6.3.2 United States Histopathology Services Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Histopathology Services Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Histopathology Services Sales Value, 2019-2030
6.4.2 Europe Histopathology Services Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Histopathology Services Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Histopathology Services Sales Value, 2019-2030
6.5.2 China Histopathology Services Sales Value by Type (%), 2023 VS 2030
6.5.3 China Histopathology Services Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Histopathology Services Sales Value, 2019-2030
6.6.2 Japan Histopathology Services Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Histopathology Services Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Histopathology Services Sales Value, 2019-2030
6.7.2 South Korea Histopathology Services Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Histopathology Services Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Histopathology Services Sales Value, 2019-2030
6.8.2 Southeast Asia Histopathology Services Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Histopathology Services Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Histopathology Services Sales Value, 2019-2030
6.9.2 India Histopathology Services Sales Value by Type (%), 2023 VS 2030
6.9.3 India Histopathology Services Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Sonic Healthcare Limited
7.1.1 Sonic Healthcare Limited Profile
7.1.2 Sonic Healthcare Limited Main Business
7.1.3 Sonic Healthcare Limited Histopathology Services Products, Services and Solutions
7.1.4 Sonic Healthcare Limited Histopathology Services Revenue (US$ Million) & (2019-2024)
7.1.5 Sonic Healthcare Limited Recent Developments
7.2 Laboratory Corporation of America Holdings
7.2.1 Laboratory Corporation of America Holdings Profile
7.2.2 Laboratory Corporation of America Holdings Main Business
7.2.3 Laboratory Corporation of America Holdings Histopathology Services Products, Services and Solutions
7.2.4 Laboratory Corporation of America Holdings Histopathology Services Revenue (US$ Million) & (2019-2024)
7.2.5 Laboratory Corporation of America Holdings Recent Developments
7.3 Acculabs Diagnostics UK Ltd
7.3.1 Acculabs Diagnostics UK Ltd Profile
7.3.2 Acculabs Diagnostics UK Ltd Main Business
7.3.3 Acculabs Diagnostics UK Ltd Histopathology Services Products, Services and Solutions
7.3.4 Acculabs Diagnostics UK Ltd Histopathology Services Revenue (US$ Million) & (2019-2024)
7.3.5 TPL Path Labs Recent Developments
7.4 TPL Path Labs
7.4.1 TPL Path Labs Profile
7.4.2 TPL Path Labs Main Business
7.4.3 TPL Path Labs Histopathology Services Products, Services and Solutions
7.4.4 TPL Path Labs Histopathology Services Revenue (US$ Million) & (2019-2024)
7.4.5 TPL Path Labs Recent Developments
7.5 UNILABS
7.5.1 UNILABS Profile
7.5.2 UNILABS Main Business
7.5.3 UNILABS Histopathology Services Products, Services and Solutions
7.5.4 UNILABS Histopathology Services Revenue (US$ Million) & (2019-2024)
7.5.5 UNILABS Recent Developments
7.6 Cureline Global Translational CRO
7.6.1 Cureline Global Translational CRO Profile
7.6.2 Cureline Global Translational CRO Main Business
7.6.3 Cureline Global Translational CRO Histopathology Services Products, Services and Solutions
7.6.4 Cureline Global Translational CRO Histopathology Services Revenue (US$ Million) & (2019-2024)
7.6.5 Cureline Global Translational CRO Recent Developments
7.7 Targos
7.7.1 Targos Profile
7.7.2 Targos Main Business
7.7.3 Targos Histopathology Services Products, Services and Solutions
7.7.4 Targos Histopathology Services Revenue (US$ Million) & (2019-2024)
7.7.5 Targos Recent Developments
7.8 Cellular Pathology Services
7.8.1 Cellular Pathology Services Profile
7.8.2 Cellular Pathology Services Main Business
7.8.3 Cellular Pathology Services Histopathology Services Products, Services and Solutions
7.8.4 Cellular Pathology Services Histopathology Services Revenue (US$ Million) & (2019-2024)
7.8.5 Cellular Pathology Services Recent Developments
7.9 Experimental Pathology Laboratories Inc (EPL)
7.9.1 Experimental Pathology Laboratories Inc (EPL) Profile
7.9.2 Experimental Pathology Laboratories Inc (EPL) Main Business
7.9.3 Experimental Pathology Laboratories Inc (EPL) Histopathology Services Products, Services and Solutions
7.9.4 Experimental Pathology Laboratories Inc (EPL) Histopathology Services Revenue (US$ Million) & (2019-2024)
7.9.5 Experimental Pathology Laboratories Inc (EPL) Recent Developments
7.10 CHARLES RIVER LABORATORIES, INC.
7.10.1 CHARLES RIVER LABORATORIES, INC. Profile
7.10.2 CHARLES RIVER LABORATORIES, INC. Main Business
7.10.3 CHARLES RIVER LABORATORIES, INC. Histopathology Services Products, Services and Solutions
7.10.4 CHARLES RIVER LABORATORIES, INC. Histopathology Services Revenue (US$ Million) & (2019-2024)
7.10.5 CHARLES RIVER LABORATORIES, INC. Recent Developments
8 Industry Chain Analysis
8.1 Histopathology Services Industrial Chain
8.2 Histopathology Services Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Histopathology Services Sales Model
8.5.2 Sales Channel
8.5.3 Histopathology Services Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Sonic Healthcare Limited
Laboratory Corporation of America Holdings
Acculabs Diagnostics UK Ltd
TPL Path Labs
UNILABS
Cureline Global Translational CRO
Targos
Cellular Pathology Services
Experimental Pathology Laboratories Inc (EPL)
CHARLES RIVER LABORATORIES, INC.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.